CD274 and hepatocellular carcinoma: ZA plus thymosin α1 or anti-PD-L1 therapy was found to significantly relieve immunosuppression in PCA cells or HCC, stimulate pro-inflammatory macrophages, and activate cytotoxic T cells [316–318].